Collaborative Study on Four-dimensional Fetal Echocardiography between 11 to 15 Weeks of Pregnancy

Objectives—Accumulating evidence supports a role for 2-dimensional fetal echocar- diography in the first trimester of pregnancy for the identification of congenital heart defects. Our objective was to investigate the role of 4-dimensional (4D) sonography in the identification of congenital heart defects between 11 and 15 weeks of pregnancy. Methods—This study included 4 centers with expertise in first-trimester 4D fetal echocardiography. Fetuses with and without confirmed heart defects were evaluated between 11 and 15 weeks and their volume data sets were uploaded onto a centralized file transfer protocol server. Results—Forty-eight volume data sets from fetuses with normal (n = 17) and abnormal (n = 16) hearts were evaluated. Overall, the median (range) accuracy, sensitivity, and specificity, as well as the positive and negative likelihood ratios, for the identification of fetuses with congenital heart defects were 79% (77%–83%), 90% (70%–96%), 59% (58%–93%), 2.35 (2.05–9.80), and 0.18 (0.08–0.32), respectively. Conclusions—(1) Four-dimensional fetal echocardiography can be performed in the first and early second trimesters of pregnancy; and (2) 4D volume data sets obtained from fetuses between 11 and 15 weeks can be remotely acquired and accurately inter- preted by different centers.